Per the prescribing information, it is also recommended that a reduction in the dose of pre-existing insulin secretagogue medications be considered when initiating liraglutide to minimize the risk of treatment-emergent hypoglycemia
M., Mehta, A., Majety, P., Grandhi, G
[6] These agents were initially developed for type 2 diabetes management but have demonstrated significant efficacy in weight reduction, leading to their expanded use in obesity treatment
Ongoing Monitoring and Support Patients receive continued check-ins, progress monitoring, and care plan adjustments throughout the program under licensed provider oversight
[1] This consistent weekly schedule is designed to maintain stable drug concentrations in the bloodstream and optimize glycemic control or weight management outcomes
A buttock lift is also performed during a body lift